Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasm Metastasis 1Fibrosis 1Esophageal Neoplasms 1Carcinoma, Hepatocellular 1Advanced Biliary Tract Carcinoma 1

Interventions

Magnetic Resonance Spectroscopy 2tremelimumab 1sofosbuvir-velpatasvir drug combination 1durvalumab 1atezolizumab 1Specimen Handling 1Simvastatin 1Radiotherapy 1Radiation 1Musculoskeletal Manipulations 1Losartan 1Liver Transplantation 1Gemcitabine 1Breath Tests 1Blood Specimen Collection 1Bevacizumab 1Aspirin 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fibrosis × Simvastatin × 90 days × Clear all
NCT02968810 2026-05-29

Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis

National Cancer Institute (NCI)

Phase 2 Active not recruiting
52 enrolled 15 charts
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡